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The risk of cervical cancer, one of the most prevalent cancers in the world, is determined by two viruses. Human papillomavirus (HPV) is the
main risk factor for developing cervical cancer. However, although little known, it is well substantiated that the human Parvovirus adeno-
associated virus type 2 (AAV), and its encoded Rep78 protein, interacts with HPV and lowers the risk of cervical cancer. HPV also contributes to
AAV inhibition by serving as a helper virus for AAV and stimulating higher AAV replication levels. Here we surveyed four HPV-16 early genes,
E1, E2, E6 and E7, for their ability to increase/decrease the basal level of AAV replication in stratifying squamous epithelium (the epithelial raft
culture system). It was found that the HPV-16 E1, E2 and E6 genes were able to help/enhance AAV-2 replication in epithelial raft cultures. Under
these conditions, with all the HPV genes being expressed from the AAV p5 promoter, E1 appeared to have the strongest enhancing effect on AAV
DNA replication (Southern blot), RNA expression (RT-PCR), protein expression (Western blot) and AAV virion production (2 plate-Southern
blot). Further study of E1 mutants showed that the carboxy-half of E1, the putative helicase/ATPase domain, was the main contributor of helper
activity. These data are important for understanding the HPV–AAV interaction and its effect on modifying cervical cancer risk. These data also
suggest the possibility that the identified HPV helper genes may be useful in the generation of recombinant (r)AAV virions for gene therapy, as
rAAV is increasing in popularity for such purposes.
D 2005 Elsevier Inc. All rights reserved.Keywords: Adeno-associated virus; Human papillomavirus; Helper; Enhance; ReplicationIntroduction
Taxonomically AAV is a Dependovirus , a genus of
Parvoviridae. This categorization reflects AAV’s usual require-
ment for co-infection with adenovirus (Ad) (Casto et al., 1967;
Mayor et al., 1967), herpes simplex virus (HSV) (Buller et al.,
1981; Mayor et al., 1974) or human papillomavirus (HPV)0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.08.039
Abbreviations: HPV, human papillomavirus; AAV, adeno-associated virus;
GFP, green fluorescent protein; MOI, multiplicity of infection; PHFK, primary
human foreskin keratinocytes.
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E-mail address: hermonatpaull@uams.edu (P.L. Hermonat).(Ogston et al., 2000; Meyers et al., 2001) in order for AAV
replication to occur. Thus, AAV receives Fhelper functions_
from the helper virus (Ad, HSVor HPV) which allows AAV to
replicate and produce progeny AAV. In return, AAV usually
inhibits the DNA replication and oncogenic abilities of its
helper viruses. This helper virus dependence and bi-directional
interaction is nearly unique among wild-type viruses and is
important for the generation of systems for generating
recombinant (r)AAV for gene therapy purposes. Moreover,
the relationship of AAV with HPV is particularly important in
regards to human health. With two new epidemiologic studies
published recently (Coker et al., 2001, Smith et al., 2001), there
is now significant data which confirm earlier studies (Georg-
Fries et al., 1984; Mayor et al., 1976) and firmly establish that6) 532 – 540
www.e
Fig. 1. Structure of AAV/HPV-E1, E2, E6 and E7 vectors. Shown are the
structures of AAV/Neo and the four AAV/HPV vectors, AAV/E1, E1-5V, E1-3V,
E2, E6 and E7. The names are indicated to the left of the vector structural map.
Also shown are the terminal repeats (TR) as black rectangles, the AAV p5 and
simian virus 40 (SV40) early promoter and the Neomycin resistance gene (Neo)
as a box with Neo written within.
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¨0.3–0.4). There is also a plethora of laboratory data
supporting this conclusion (for example, Hermonat, 1994;
Hermonat et al., 1997; Horer et al., 1995; Su and Wu, 1996).
While the adenovirus (Duan et al., 1999; Samulski and
Shenk, 1988; Richardson and Westphal, 1981; West et al.,
1987) and herpes virus helper genes (Mishra and Rose, 1990;
Weindler and Heibronn, 1991) have been studied, HPV helper
genes are largely unstudied. Walz et al. (1997) demonstrated
that AAV and HPV were preferentially found co-infecting the
cervical epithelium. While not a direct demonstration of helper
function, it provided coincidental and consistent data with this
hypothesis first presented in 1989 (Hermonat, 1989). Ogston et
al. (2000) next demonstrated that AAV replication takes place
in HPV-16 E2 positive cells. Most recently, Meyers et al.
(2001) demonstrated in a study in a human skin model in
culture, in which both HPV and AAV are productive, that co-
HPV infection increased AAV DNA replications many fold
over AAV-only infection. With AAV’s ever increasingly
popularity as a gene therapy vector (Hermonat and Muzyczka,
1984; Tratschin et al., 1984; Liu et al., 2005) and its negative
association with cervical cancer, it appears necessary to analyze
the HPV genes involved in helper functions for AAV. Here, we
find that multiple HPV-16 genes, including E1, E2 and E6,
helping AAV, with the helicase function of E1 being the most
significant single helper element.
Results
E1, E2 and E6 help AAV DNA replication
We have shown earlier that AAV-2 has the ability to
autonomous replicate in differentiating keratinocytes of the
organotypic epithelial raft cell culture system, which closely
mimics normal stratified squamous epithelium and likely
represents the natural host tissue for AAV-2 (Meyers et al.,
2000, 2001). In this study, we use the raft culture system to
observe potential HPV early genes (E1, E2, E6 and E7) helper
functions for AAV replication. The structure of the expression
plasmids is shown in Fig. 1. The plasmid AAV/Neo (no HPV
gene) served as a negative control. All of the HPV genes were
expressed from the same transcriptional promoter, AAV p5.
There were no RNA splice donor or acceptor sites remaining in
the vector sequences outside that present in the specific HPV
gene. PHFK monolayers were transfected with the HPV
expression plasmids for E1, E2, E6 and E7 on day 0 and then
1 day later infected with wt AAV as described in more detail in
the Materials and methods section. This order of introduction
was done so that the HPV product would be present at the
initiation of AAV DNA replication as AAV initiates DNA
replication relatively fast in stratified squamous epithelium
(Meyers et al., 2000). Our plasmid transfection efficiency for
the keratinocytes, determined by lipofecting a plasmid expres-
sing green fluorescent protein (GFP), was 46% (average of four
experiments) as shown in Fig. 2. The HPV-transfected/AAV-
infected keratinocytes were then trypsinized and seeded onto
collagen disks with embedded fibroblasts. The next day, therafts were raised to the air to stimulate formation of a stratified
squamous epithelium.
First, the ability of our vectors to express the HPV genes
was analyzed. The expression plasmid of each HPV early gene
(E1, E2, E6 and E7) was individually transfected into PHFK,
then subsequently infected with AAV, the cells used to form
skin rafts, and polyA-selected RNAwas isolated on day 5. Fig.
3 (representative of three experiments) demonstrates that the
transfected HPV genes were significantly expressed as
analyzed by RT-PCR. The cellular housekeeping gene expres-
sion control was TFIIB. Relative transcript levels could be
judged by comparing the HPV and TFIIB cDNA levels. As
shown, the mRNA levels of all of HPV genes were
comparable, with E2 mRNA levels being perhaps slightly
lower. PCR-only failed to generate any products indicating that
our polyA RNA samples were free of DNA.
Next, AAV replication levels were compared. The structure
of the experiment is shown in Fig. 4A. As in Fig. 3, each HPV
early gene (E1, E2, E6 and E7) was individually transfected
into PHFK, then subsequently infected with AAV and used to
form skin rafts. DNA was harvested from total rafts on day 5
and resulting AAV DNA levels compared. The DNA (10 Ag
total cellular DNA each lane) was DpnI digested, size
separated and Southern blotted. Fig. 4B shows a representative
Southern blot analysis, while Fig. 4C shows a quantification of
five equivalent experiments upon densitometric analysis. To
demonstrate equivalent DNA loading, Fig. 4D shows the
ethidium bromide stained agarose gel (corresponding to the
Southern blot in B) before transfer, demonstrating total DNA
content. Finally, Fig. 4E lists the P values of the indicated
comparisons. These data indicated that under our experimental
conditions, the E1 gene stimulated the highest AAV DNA
replication level, followed by E2 and E6. In contrast, E7 had no
significant effect compared to the AAV/Neo control vector. We
further analyzed E1 to observe if the helper effect was dosage-
dependent. As shown in Fig. 5, E1 showed a dosage-dependent
Fig. 2. Plasmid transfection efficiency in keratinocytes. The plasmid AAV/GFP
was transfected into keratinocytes as the same method as the AAV/HPV
plasmids. Panel A shows the analysis of the untransfected and GFP-transfected
keratinocytes by FACS after treatment with trypsin. The results showed 46%
(average of four experiments) of the cells transfected by GFP had a positive
fluorescence signal. Panel B shows the fluorescence of untransfected and AAV/
GFP-infected cells under fluorescence microscopy.
Fig. 3. Expression of HPV genes in transfected keratinocytes. HPV mRNA
levels were analyzed by RT-PCR for the presence of the HPV E1, E2, E6 or E7
mRNAs as described in the Materials and methods section. The positive contro
was the AAV/E1, E2, E6 or E7 vector plasmid as a template respectively. PCR
alone, using each RNA sample, gave no signal. The cellular housekeeping gene
control was the cellular transcription factor TFIIB. Note that the AAV/HPV
transfected stratified squamous epithelium rafts expressed correct size-specific
mRNA while AAV/Neo vector did not.
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resulting in increasing AAV DNA levels.
E1, E2 and E6 increase AAV mRNA expression by RT-PCR
analysis
Next, an analysis of HPV early genes effects on AAV
transcriptional activity was undertaken.
The experiment was identical to those AAV DNA experi-
ments shown in Figs. 4 and 5 with the exception that polyA-
selected RNA was isolated. The mRNA samples were then
analyzed by RT-PCR and PCR for AAV rep and lip-cap
containing mRNA as described in the Materials and methods
section. Plasmid pSM620, which contains the complete AAV
genome, was a template for PCR amplification to give the
correct sized product. The cellular housekeeping gene expres-
sion control was TFIIB. Again, relative transcript levels could
be judged by comparing the rep and TFIIB cDNA levels. Three
such RT-PCR experiments gave consistent results. Shown in
Fig. 6A, E1-transfected rafts had higher AAV rep mRNA
expression (a higher rep:TFIIB ratio), than those transfected
with E2 or E6, while the control Neo-only and E7 transfections
gave the lowest rep mRNA levels. These results are fully
consistent with the hierarchy of the AAV DNA replication
levels. This is noteworthy as rep is required for AAV DNA
replication. Fig. 6B (three separate experiments) similarly
studied cap mRNA expression. As determined in three such
experiments, the hierarchy of cap mRNA also followed DNAreplication levels, with E1 having the highest helping activity,
E2 and E6 with intermediate helper activity and E7 with little
effect or possibly a slight decrease in cap expression. The
mRNA samples were also analyzed by direct PCR. As shown
in Fig. 6C, PCR-only failed to generate any products indicating
that our polyA RNA samples were free of DNA.
E1, E2 and E6 increase AAV capsid protein production by
Western blot analysis
Next, the effect of HPV helper genes on AAV protein levels
was carried out, again as in Figs. 4 and 5. Total cellular protein
was isolated from individual rafts and analyzed for AAV rep
and cap proteins. Coomassie blue stained gel was used to show
that the same amount of total protein was loaded (Fig. 7C). Fig.
7A shows a Western blot using an anti-Rep monoclonal
antibody. Three similar experiments gave consistent results
and demonstrated that Rep78/68 protein levels were not
significantly changed by any of the HPV genes. This is
different than the rep mRNA levels, but this was a fully
reproducible result in all three experiments.
Equivalent Western blots were probed with anti-Cap
antibody as shown in Fig. 7B. Unlike Rep proteins, HPV E1-
transfected rafts expressed the highest levels of VP3 capsid
protein. Transfection of E2 and E6 also slightly increased VP3
protein expression. Similar to Southern blot and RT-PCRl
-
Fig. 4. HPV early genes enhance AAV DNA replication. Each HPV early gene
(E1, E2, E6 and E7) was individually transfected into AAV-infected PHFK
which were then used to form skin rafts. Panel A shows the structure of the
experiment. Panel B shows the resulting Southern blot analysis of day 5 total
cellular DNA (10 Ag). Monomer duplex (md) and single stranded DNA (ss) are
indicated to the left. The bottom half of the blot has been enhanced to show the
ss DNA levels which were of lower intensity when compared to the md DNA.
Panel C shows a quantification of five equivalent experiments upon
densitometric analysis. Panel D shows the ethidium bromide stained agarose
gel (corresponding to the Southern blot in panel B) before transfer,
demonstrating total DNA content. Note that E1 enhanced AAV replication
the most, followed by E2 and E6. Panel E lists the P values of the indicated
comparisons.
Fig. 5. E1 helps AAV DNA replication in a dose-dependent manner. Shown is a
similar experiment to those in Fig. 4, but in which increasing amounts of E1
were introduced. Note that E1 enhanced AAV replication in a dose-dependent
manner.
Fig. 6. HPV early genes enhance AAV mRNA expression. Shown is a similar
experiment to those of Figs. 4 and 5, except that polyA-selected mRNA was
isolated from the indicated HPVearly gene-transfected rafts. Samples were then
analyzed by RT-PCR and PCR. The positive control used PSM620 plasmid
which contains complete AAVas a template. Cellular TFIIB mRNA served as a
housekeeping gene control. Panel A shows AAV rep mRNA expression (one of
three experiments giving similar results). Using the AAV rep primer set, E1-
transfected rafts showed higher rep expression than E2, E6, E7 and vector
(AAV/Neo) introduced rafts. Panel B shows AAV cap mRNA expression.
Using the AAV cap primer set, E1-transfected raft showed higher cap
expression than other samples. (C) The mRNA samples were also analyzed
by direct PCR and failed to generate products.
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results were also repeatable over three experiments. As single
stranded DNA is believed to reflect genomic DNA encapsida-
tion, this provides mutual confirmation and support for
correlating E1 with high VP3 levels.
E1 helps to produce more AAV infectious virions by two-plate
assay
Next, we analyzed HPV helper gene effects on the complete
AAV life cycle, the production of AAV infectious units. These
infectious units were measured using a two-plate assay(Meyers et al., 2000). The first plate part of the experiment
was again carried out as depicted in Fig. 8A. However, instead
of isolating DNA, RNA or protein, the rafts were processed to
result in putative virus stocks as described in the Materials and
methods section. The stocks were treated with DNAse I to
prevent the possibility of free DNA transfer. These putative
virus stocks were then tested for the level infectious units
(virions) by infecting a second plate of adenovirus-infected 293
cells. At 36 h post-infection of 293 cells by putative AAV virus
from the original rafts, total DNA (10 Ag) was isolated and
analyzed by Southern blot for AAV DNA levels. As shown in
Fig. 8B, it can be seen that the production of AAV infectious
Fig. 9. The carboxy-half of E1 helps AAV replication. Panel A shows a map o
the functional domains of the E1 protein. Panel B shows a representative o
three Southern blot analysis of the AAV infect-raft DNA transfected with E1
E1-5V or E1-3V. Panel C shows a quantification of the Southern blot afte
densitometric analysis. Note that E1-3V had a much strong enhancing activity
than E1-5. These data suggest that the carboxy-half of E1 contains the majo
Fig. 7. HPV early genes enhance AAV cap protein production. Shown is a
similar experiment to those of Figs. 4 and 5, except that total protein was
isolated from the indicated HPV early gene-transfected rafts. These samples
were then analyzed by Western blot using anti-AAV rep and anti-cap antibody.
Panel A shows a Western blot (one of three experiments), using anti-rep
monoclonal antibody showed Rep78/68 levels was not significantly effected by
the HPV genes. Panel B shows a Western blot probed with anti-cap monoclonal
antibody and peroxidase-labeled secondary antibody. Note that E1-transfected
raft had the highest cap protein production. (C) Coomassie blue stained gel was
used as controls to demonstrate that similar amounts of total proteins were
loaded.
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helped AAV virion production the most, followed by E6, then
E2. Again, E7 appeared to inhibit AAV virion production
(consistent among three experiments). It should be noted thatFig. 8. HPV early genes helper abilities for AAV virions by two-plate assay.
The generation of AAV virions was measured by the ability of raft lysates to
infect 293 cells infected with adenovirus. (A) The experimental scheme for
showing infectious virus production is diagrammatically presented. (B) As in
Figs. 4–6, rafts were transfected by HPV early genes or vector as control.
Individual putative virus stock was generated and used to infect 293 cells with
adenovirus. At 36 h post-infection, total DNA was isolated from the 293 cells
and analyzed by Southern blot for AAV. Note that the E1-transfected raft
lysates contained more AAV virions than E2-, E6- and E7-transfected rafts or
control rafts. Panel C shows the ethidium bromide stained agarose gel before
transfer, demonstrating total DNA content.
AAV helper domain and suggest that the helper function may be through E1
helicase activity.f
f
,
r
rinfectious unit levels (Fig. 8), VP3 levels (Fig. 7) and single
stranded DNA levels (Fig. 2) are all mutually supportive and
provide a firm conclusion with regards to the hierarchy of level
of helper function provided by E1, E2, E6 and E7.
The carboxy-half of E1 helps AAV replication
We then focused more closely on HPV E1 as it had the
highest level of helper activity. The E1 protein is divided
roughly into two halves, an E2-binding/ori interaction domain
in the amino-half and a helicase/ATPase domain in the
carboxy-half (Amin et al., 2000; White et al., 2001; Wilson
et al., 2002; Woytek et al., 2001). Therefore, we divided E1
into two half genes and generated AAV vectors AAV/E1-5V and
AAV/E1-3V each containing either the E2 interaction or helicase
domain (Fig. 9A). Both of these truncated E1 genes were
compared to full-length E1 in experiments designed essentially
as in Fig. 4A to observe AAV helper function. As shown in
Figs. 9B and C, AAV/E1-3V clearly had a much stronger
helping activity over AAV/E1-5V and comparable to AAV/E1
(three experiment). These data strongly suggest that the
carboxy-half of E1 contains the major AAV helper domain.
Discussion
While AAV is able to replicate without the presence a helper
virus under certain conditions and in certain tissue (Meyers et
H. You et al. / Virology 344 (2006) 532–540 537al., 2000, 2001; Wang and Srivastava, 1998; Yakobsun et al.,
1987, 1989; Yalkinoglu et al., 1988), it is clear that the
presence of viral helper genes greatly facilitates the production
of both wild type and rAAV. This study demonstrates that
multiple HPV-16 genes, including E1, E2 and E6, contribute in
enhancing/helping AAV replication and progeny formation in
stratified squamous epithelium. E1, E2 and E6 were all
expressed from the same transcriptional promoter, and there
are no significant dual splice donor–acceptor sites remaining
within the single HPV genes. Thus, if all the HPV genes were
expressed at approximately the same level, as suggested by Fig.
3, this indicates that E1 provided the highest amount of helper
function. Moreover, it is interesting that three different HPV
genes appear to enhance AAV’s full life cycle. That is, DNA,
RNA and protein (cap protein anyway) levels are all up-
regulated. This is somewhat different from the adenovirus
helper genes which appear to help AAV in more specific steps
of gene expression. The lack of helper function of E7 may
reflect its ability to bind the AAV Rep78 replication protein and
to inhibit some of its functions (Hermonat et al., 2000).
It should be pointed out that E1, E2 and E6 are proteins with
very different biochemical activities and biological functions.
E1’s primary function is being a helicase, opening up the HPV
origin of replication (ori) and thus promoting the initiation of
DNA synthesis (Hughes and Romanos, 1993; Wilson et al.,
2002). E2 is a transcription factor and facilitates E1 binding to
the HPV ori (Berg and Stenlund, 1997; Woytek et al., 2001).
E6 is an oncoprotein and is important for wart formation
(Munger and Howley, 2002). Thus, we find it surprising that
most aspects of AAV biology are up-regulated by all three of
these genes in a relatively similar manner. We likely can gain
some insight regarding the mechanism of action of HPV-16
helper gene function by reviewing and comparing them to
adenovirus helper gene functions. Presumably many of the Ad
helper functions must be duplicated by HPV. Ad is the best
studied helper for AAV, and five regions of this virus are
involved in providing AAV helper function. These include
E1A, E1B, E2A, E4 (ORF6) and VA (Janik et al., 1989; Jay et
al., 1989; McPherson et al., 1982; Strauss et al., 1976). Yet, the
only straightforward similarity is HPV E6 and adenovirus E1A,
both of which are oncoproteins which bind p53 (38).
Focusing on E1, we hypothesize that E1’s helicase function
may add to or augment Rep78’s own endogenous helicase
function. There is also the potential that Rep78 and E1 directly
interact, both being the respective replication proteins of these
two virus types. Mutational analysis of E1, which we have
initiated here, will ultimately provide additional information as
to the mechanism of E1 helper function. It should also be noted
that the E1 stimulated higher rep RNA levels (Fig. 6), yet very
little change (possibly slightly lower) in Rep78 protein levels
(Fig. 7). We are not aware that E1 has shown any activity in
affecting translation, yet this appears superficially consistent
with our data. Perhaps HPV E1’s closest match among the
adenovirus helper genes may be adenovirus E2A. E1 has an
ATP-requiring helicase activity, and E2A has a single stranded
DNA binding activity which may give outcomes similar to a
helicase. In fact, we can map the helper effect of E1 to thedomain which includes the helicase function, supporting the
hypothesis that E1 helicase function is the helper effect
mechanism of action.
Similar analyses can and will be done on E2 and E6 to
determine their mechanisms of action for helper function on
AAV. It seems reasonable that E6 has an analogous helper role
to adenovirus E1B, both known to bind p53. E2’s match in the
adenovirus helper gene list is more difficult as E2 functions
largely as a transcription factor, and while adenovirus E1A has
such an activity, these two proteins are otherwise very
dissimilar. These data also suggest the possibility that, upon
understanding each helper gene (adenovirus, herpes virus or
HPV) mechanism of action, we can combine various cocktails
of helper genes to get better or more specific results in the
generation of rAAV products or gene therapy. In fact,
preliminary results suggest this is the case (Liu, You and
Hermonat, unpublished). Information as to how HPV helps
AAV is important for developing new techniques for the
generating rAAV for gene therapy as well as understanding the
HPV–AAV interaction and its effect on cervical cancer risk.
Clearly, as demonstrated in co-infection experiments in skin,
both HPV and AAV, when present at moderate levels,
accentuate each other’s replication. This suggests that these
two viruses will always be preferentially found together as
traveling partners in the genital tract. If you have only HPV
infection or low AAV infection, you are at greater risk for
developing cancer (Coker et al., 2001; Smith et al., 2001). This
study establishes the level of contribution of specific HPV-16
genes for their helper function for increasing AAV replication
in the stratified squamous epithelium. Such knowledge is
important for our understanding of AAV/HPV interaction with
regards to the development of cervical cancer as well as for the
potential that certain HPV genes may be useful in the
generation of recombinant AAV virus for gene therapy.
Materials and methods
Construction of plasmids
We used standard recombinant DNA methodologies to
generate expression plasmids for E1, E2, E6 and E7 (Liu et al.,
2000, 2001, 2005; Chiriva-Internati et al., 2002, 2003; You et
al., 2002). Briefly, the wild-type AAV genome pSM620 was
partially digested with BsaI to delete the internal AAV
sequences from map units 6–95 (nt 286–4460), and a
specially designed polylinker was ligated in place, resulting
in the AAV vector plasmid dl6-95/PL1. Into this polylinker,
the neomycin (Neo) resistance gene and one of the HPV16 E1,
E2, E6 and E7 open reading frames (cloned by PCR
amplification from the HPV-16 plasmid pAT-HPV-16) were
sequentially ligated (see Fig. 1 for structures). AAV/Neo, with
no HPV gene, was also generated. The role of AAV/Neo was
to serve as an HPV-negative control vector. Two additional E1
vectors were also generated. One contained the amino-half of
E1, E1-5V (aa 1 to 365). The primer used was 5V-ATA-
GATCTTCTACCATGGCTGATCCTG-3 and 5V-ATCTCGAG-
TAGGTAGGCCCATTGTACCATC-3 which targeted
Gene Primer
position
Primer sequences Size of
PCR
products
(bp)
E1 Up nt 859 TCTACCATGGCTGATCCTG 1986
Down nt 2844 TATATGGTCACGTAGGTC
E2 Up nt 2742 ACAAGGAAAACGATGGAGAC 1136
Down nt 3877 GTTGTGGATGCAGTATCAAG
E6 Up nt 57 CGGTTAGTATAAAAGCAG 523
Down nt 579 GGCTCGAGGGTGTATCTCC
E7 Up nt 559 ATCATGCATGGAGATACACC 322
Down nt 880 GGCTCCAGGCAGGATCAGCC
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The other was the carboxy-half, E1-3V (aa 353 to 649). The
primer used was 5V-ATAGATCTATGAGACA CGCCA-
GAATGGATAC-3 and 5V-CCGCTCGAGTATATGGTCACG-
TAGGTC-3 which targeted amplification of the HPV-16
sequences from nt 1866 to 2844. In the case of E1-5V, an in-
frame stop codon TAG was included at the end of the open
reading frame. In the case of E1-3V, a new in-frame initiation
methionine codon was included to allow for translation of the
open reading frame. The enhanced green fluorescent Protein
(GFP) cDNA was derived from plasmid pEGFP-N1 (BD
Biosciences Clontech) and inserted to the downstream of p5
promoter of dl6-95 vector to generate AAV/GFP.
Analysis of transfection efficiency
Keratinocytes (Cambrex) were cultured in six-well plates
with the keratinocyte medium (Cambrex). When the cell
density was at 80% confluence, they were transfected with
1.0 Ag of the AAV/GFP plasmid using FuGENE 6 liposomal
reagent (Roche Diagnostics) according to the manufacture’s
recommendation. At 72 h of post-transfection, the keratino-
cytes were observed under an inverted fluorescent microscope.
At the same time, the cells were also harvested and detected by
FACS as the routine method.
Assaying AAV replication and HPV helper gene activity in the
organotypic epithelial raft culture system
Primary human foreskin keratinocytes (PHFK) were pur-
chased from Clonetics Inc. (San Diego, CA) and cultured in
keratinocyte serum-free medium (Invitrogen, Carlsbad, CA) in
37 -C under 5% CO2. Cells were fed every other day. A
representative experiment of this design is shown in Fig. 2A.
On day 0, 106 PHFK monolayers were transfected with 4 Ag of
the AAV/HPV (AAV/E1, E1-5V, E1-3V, E2, E6 or E7) plasmid
using Fugene6 (Roche, Indianapolis, IN) according to manu-
facturer’s instructions. Transfection of 4 Ag AAV/Neo (no HPV
gene) served as a control. The next day (day 1), these cells
were infected with 108 infectious units of wild-type AAV-2
virus (MOI ¨100). Six hours later, the cells were trypsinized
and seeded onto J2 fibroblast-containing collagen rafts as
described previously (Meyers et al., 2000, 2001). Next, the
rafts (later on day 1) were raised to the air interface and allowed
to form a stratified squamous epithelium and were harvested on
day 5. Experiments were repeated 3–8 times.
Southern blot analysis of AAV DNA replication
All rafts were harvested on day 5. After washing with PBS
twice, total DNA was extracted as previously described
(Meyers et al., 2000, 2001). Total cellular DNA (10 Ag) was
agarose gel sized separated, Southern blotted and probed with
32P-AAV capsid gene DNA. This allowed for the specific
identification of the wild-type AAV genome, without the
complication of also identifying the AAV/HPV helper plasmid
DNA. Finally, a quantification of the Southern blot was doneby densitometric analysis using the Alpha Imager 2000 (Alpha
Innotech Corporation, San Leandro, CA).
RT-PCR analysis of AAV and HPV mRNA expression
Total RNA was isolated from rafts on day 5 using Trizol
reagent (Invitrogen, Carlsbad, CA), according to the manufac-
turer protocol and treated with 5 U/Ag of RNase-free DNase I
at 37 -C for 2 h. Messenger polyA RNA then was isolated
using the Oligotex mRNA Mini Kit (QIAGEN Inc. Valencia,
CA) according to the supplier’s instruction. The first-strand
cDNA synthesis was performed at 37 -C for 1 h in a final
volume of 25 Al reaction buffer (1 Ag mRNA; 50 mM Tris–
HCl, pH8.3; 75 mM KCl; 3 mM MgCl2; 10 mM DTT; 0.5 Ag
oligo(dT)15; 0.5 mM each of the four dNTPs; 30U of RNasin
and 200 U of M-MLV Reverse Transcriptase RNase H Minus
(Promega Co., Madison, WI)). PCR amplification (32 cycles)
of the cDNAwas performed in a 100-Al reaction volume which
contained 2.5 U Taq DNA polymerase; 10 mM Tris–HCl,
pH8.3; 50 mM KCl; 2 mM MgCl2; 0.2 mM each of the four
dNTPs; 1 AM of each upstream and downstream primer
specific for the cDNA template and 10 Al cDNA templates.
The primer set used for AAV rep was 5V-TGAAGCGG-
GAGGTTTGAACG-3V and 5V-TCCATATTAGTCCACGCC-
3V, which targeted amplification of the AAV sequences from
nt 291 to 821. The primer set used for AAV cap was 5V-
CCCTCGAGCACGACAAAG-3V and 5V-GTCGTACCGT-
CATTCTGC-3 which targeted amplification of the AAV
sequences from nt 2417 to 3175. The TFIIB (housekeeping
gene) was also analyzed in each RT-PCR mix. The products
were size separated by agarose gel electrophoresis, stained with
ethidium bromide and photographed.
For analysis of HPV mRNA expression keratinocytes were
lipofected with 1.0 Ag of AAV/E1, AAV/E2 AAV/E6 or AAV/
E7 plasmid using FuGENE 6. The cells were harvested at 72
h post-lipofection, and HPV mRNA expression was measured
similar to that done for AAVmRNA analysis with the exception
that different analytical primers were used, as shown below.The TFIIB (housekeeping gene) was also analyzed as
previously described (Liu et al., 2000).
Western blot analysis of AAV protein expression
For protein isolation, the rafts were washed with PBS twice
and lysed with Passive Lysis Buffer (Promega, Madison, WI).
H. You et al. / Virology 344 (2006) 532–540 5395 Ag of protein from each raft was then briefly boiled and then
electrophoresed by 10% SDS-PAGE and electroblotted. The
resulting nitrocellulose membrane was blocked by 10% milk
TBS for 1 h. Purified mouse anti-human AAV rep or cap
monoclonal antibody (mouse IgG2a, American Research
Products Inc., Belmont, MA) was added (duplicate mem-
branes) to the buffer (1:100 dilution). The membrane was
incubated at 4 -C overnight and then washed with TBS three
times. The membrane was then put into peroxidase-labeled
secondary antibody and incubated at room temperature for 1 h.
After washing the membrane three times, ECL chemilumines-
cence was applied.
Assaying for AAV virion production in the organotypic
epithelial raft (skin) culture system
Putative virus stocks were generated by freezing day 5 rafts
and grinding the rafts with mortar and pestle. The remains of
the raft were placed in 1 ml of DMEM medium, vortexed for
1 min and centrifuged at 8000 g for 15 min to remove debris,
and the supernatant was filtered through a 20-um filter. Raft
lysates were treated with Dnase I at 100 U/ml for 1 h to
eliminate unencapsidated DNA contamination. One third of
the putative virus stock was used to infect a 6-cm plate on
80% confluent monolayer 293 cells. These cells were also
infected with Ad helper virus at an MOI of 5. Any AAV
infectious units produced in the original raft would be
amplified in the Ad-infected 293 cells. After 36 h of infection,
total DNA was extracted, and 10 Ag of total cellular DNA was
analyzed for AAV DNA replication levels by agarose gel
electrophoresis, Southern blotting and probing with 32P-AAV
cap DNA probe.
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